(Source: Business Wire)Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pain Therapeutics Inc. (Nasdaq: PTIE), Animal Health International, Inc. (Nasdaq: AHII), Companhia Paranaense de Energia (NYSE: ELP), Internap Network Services Corp. (Nasdaq: INAP) and Buckeye Partners, L.P. (NYSE: BPL).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Monday's Analyst Blog:

Pain Therapeutics Feels the Hurt

Pain Therapeutics Inc. (Nasdaq: PTIE) is focused on the development of novel treatments for the management of pain and other therapeutic indications. Lead pipeline candidate, Remoxy, an abuse-deterrent version of pain drug oxycodone, should have significant commercial opportunity upon approval due to its ability to reduce the potential of drug abuse / misuse.

While we believe that Remoxy will see significant demand once launched, we are concerned that the candidate may not receive final approval at the upcoming FDA action date of December 10. Remoxy received a mixed response from an FDA advisory panel recently - we fear that the FDA might require the company to conduct additional studies to establish its abuse-deterrent qualities.

Animal Health's Nice Upside

Animal Health International, Inc. (Nasdaq: AHII), based in Dallas/Fort Worth Texas, is a leading distributor of animal health products in the U.S., focused on both the production animal and companion animal health product segments of the market. AHII reported lower than expected 1Q09 net income of $0.3M, or EPS of $0.01.

Management cited constrained production animal customer sales, as a result of volatile commodity prices during the quarter, coupled with lower sales in the companion animal business associated with the general downturn in the economy as the main drivers. We have revised our price target to reflect a more conservative medium term outlook, however believe downside risk is limited at current levels and retain a Buy rating.

COPEL a Brazilian Utility Play

We are keeping our Buy recommendation on Companhia Paranaense de Energia or COPEL (NYSE: ELP), a fully integrated electric utility operating in Brazil. The company is engaged in the generation, transmission and distribution of electricity to more than three million customers in the southern state of Paraná.

The company's second quarter results were as expected.